BRITEPath- Phase 2

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

101 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-05

Study Completion Date

2022-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

BRITEPath (BP) aims to support co-located mental health clinicians in the development of a high quality, effective, and personalized safety plan for referred patients who screen positive for depression and/or suicidal ideation.

BRITEPath utilizes BRITE, a safety planning and emotion regulation app that is loaded on the patient's smart phone and has previously been shown to be well accepted and to reduce suicide attempts compared to usual care in psychiatric inpatients (HR = 0.49). To support mental health clinicians in the development of effective safety plans, study investigators will develop Guide2Brite (G2B), which provides step-by-step instructions for the mental health clinician on how to populate BRITE onto the patient's smartphone and BRITEBoard, a clinician dashboard that tracks patient symptoms, app use, and rating on helpfulness of different interventions assessed through BRITE.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Optimizing a Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents

NCT06665620

Suicide Mental Health Disorder Anhedonia

ACTIVE_NOT_RECRUITING NA

Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application

NCT03678194

Depression Psychiatric Disorder Brain Diseases +2 more

RECRUITING NA

Screening Wizard- Phase 2

NCT04646369

Depression Suicidal Ideation

COMPLETED NA

Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

NCT02742064

Depression Bipolar Disorder

COMPLETED

Mobile Sensing and Support for Depression

NCT02776839

Depression

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

BRITEPath has 3 components: 1) BRITE, an emotion regulation and safety planning phone app that is delivered by a co-located mental health (MH) clinician to adolescents at the time of their first therapy appointment; 2) Guide2Brite, which will guide the co-located MH clinician in working with the adolescent to population content onto BRITE; and 3) BRITEBoard, which is a clinician dashboard delivered to the MH clinician and PCP.

Assignment of Interventions: This study will utilize a 1:1 randomization scheme to randomize participants to receive BRITEPath intervention or Treatment as Usual (TAU).

Hypothesis: The use of BRITEPath will decrease depressive symptoms, distress, and suicidality (any self-injurious ideation, urges, or behavior) as well as improve overall functioning compared to TAU.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Suicidal Ideation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study will use a parallel study design, where participants are randomized into two groups, BRITEPath or TAU, and will receive interventions in parallel.

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Outcomes assessors will be masked to the intervention condition at follow-up assessment time points.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BRITEPath

Participants will receive the components in BRITEPath from a mental health (MH) clinical trained by the study staff/PI's on how to implement BRITE safety planning with fidelity.

First, the MH clinician will review possible barriers to implementation of the safety plan and problem-solve appropriately with patient and parent(s); (2) BRITE is the emotion regulation/safety planning app loaded on the patient's smartphone that populated with support from Guide2BRITE; and (3) BRITEBoard, a clinician dashboard that shows app use, change in distress and symptoms ratings, and can be used for shared decision making with parents, patients, and PCPs. Clinicians will review adolescent's skill development and app content with parents. Prior to discharge or following acute increases in suicide risk.

Group Type EXPERIMENTAL

BRITEPath

Intervention Type BEHAVIORAL

BRITEPath will guide co-located mental health clinicians in the use of an emotion regulation and safety planning app (BRITE) to be loaded on the phone of depressed and suicidal adolescents in order to improve depression and reduce the likelihood of a suicide attempt.

Treatment As Usual (TAU)

Participants in the TAU group will receive treatment from their mental health clinician which may include safety planning.

Group Type ACTIVE_COMPARATOR

Treatment As Usual (TAU)

Intervention Type BEHAVIORAL

Participants in this group will receive usual care from their mental health care provider.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BRITEPath

BRITEPath will guide co-located mental health clinicians in the use of an emotion regulation and safety planning app (BRITE) to be loaded on the phone of depressed and suicidal adolescents in order to improve depression and reduce the likelihood of a suicide attempt.

Intervention Type BEHAVIORAL

Treatment As Usual (TAU)

Participants in this group will receive usual care from their mental health care provider.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Youth aged 12-26yo
2. Own a device (e.g. smartphone, iPod, tablet) with capability to download BRITE app
3. Biological or adoptive parent is willing to provide informed consent for teen to participate
4. Youth speaks and understands English
5. Positive PHQ score or provider determines youth has depressive symptoms based on clinical interaction and refers youth to the study (in cases when PHQ is not available and study staff will complete the PHQ during the screening) OR Provider can refer if they are unclear if symptoms are depressive and PHQ scoring will be used to determine youth's eligibility. OR Screening Wizard screening questionnaire (which includes the PHQ and depressive symptom questions) indicates depression OR provider/parent have concern that youth/patient has a mood or behavioral problem
6. Family agrees to see an (embedded) MH therapist at the practice
7. PHQ scores: Score of 8 or higher on PHQ-8 -or- Score of 1 or higher on #9 of PHQ-9 suicidality item

Exclusion Criteria

1. Non English speaking
2. No parent willing to provide informed consent
3. No cell phone capability of downloading BRITE app
4. Is currently experiencing mania or psychosis
5. Evidence of an intellectual or developmental disorder (IDD)
6. Life threatening medical condition that requires immediate treatment (including emergent suicidality, homicidally, abuse/neglect, or other mental or physical condition)
7. Other cognitive or medical condition preventing youth from understanding study and/or participating.
8. Currently receiving MH treatment/currently satisfied with treatment

Minimum Eligible Age

12 Years

Maximum Eligible Age

26 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No